GPX3, AKR1C4, and SPHK1 are reported to have involvement in the pathogenesis of CRC and in predicting overall survival, reinforcing the prognostic value of our TCGA and GEO cohort analysis. This evidence concerns the gene GPX3 and colorectal carcinoma.